Active Pharmaceutical Ingredient (API)

Caffeine Citrate

CNS Stimulant (Neonatal Apnea)

A salt formulation of caffeine used to treat apnea of prematurity in infants. It is a powerful CNS stimulant that acts as an adenosine receptor antagonist, increasing respiratory drive and reducing the frequency of apneic episodes in premature newborns.
Technical Profile
Reference Code
CAF464
CAS Number
69-22-7
Molecular Weight
386.32 g/mol
Chemical Class
N/A
Molecular Formula
C14H18N4O9
Therapeutic Class
N/A

Verified Brands

Medicines containing Caffeine Citrate as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.